Rasmussen syndrome
rare inflammatory neurological disease

Rasmussen syndrome, also known as Rasmussen's encephalitis, is a rare progressive autoimmune neurological disease. It is characterized by frequent and severe focal seizures, progressive neurological decline, hemiparesis (weakness on one side of the body), encephalitis, and unilateral cerebral atrophy. The disease primarily affects children under the age of 15, though adult cases have been reported. It was originally described as a form of chronic focal motor epilepsy by Dr. A. Ya. Kozhevnikov in the 1880s and separately identified as focal seizures due to chronic localized encephalitis in the 1950s by Dr. Theodore Rasmussen. It is now classified to be a cytotoxic T-cell–mediated encephalitis.
Signs and symptoms
The hallmark symptoms are focal seizures, particularly epilepsia partialis continua (EPC), a form of epilepsy characterized by continuous or near-continuous clonic movements in a localized body part. These seizures are typically resistant to standard anti-epileptic medications and often mark the early stage of the disease.
This brief starts where responsible research should: with the source description of “Rasmussen syndrome” as rare inflammatory neurological disease. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the general reference register because the source frames it as rare inflammatory neurological disease. Its deeper value depends on whether names, dates, institutions and citations support that framing.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Aug 24, 2026. The linked authority identifier is Q1637701. None of the 0 selected statements returned an explicit reference.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Rasmussen syndrome”, its source revision and the description used here.
- Expand the search: follow Rasmussen syndrome primary sources, Rasmussen syndrome archive and Rasmussen research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Rasmussen syndrome”?
- Which cited source is closest to the event, object or claim?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Rasmussen syndrome” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.